Should Physicians Offer Treatments Contrary to Published Guidelines?
When deviating from published guidelines, physicians must ensure their recommendations are based on justified belief, not personal bias.
When deviating from published guidelines, physicians must ensure their recommendations are based on justified belief, not personal bias.
Research findings suggest the need for greater adherence to a standardized set of policies aimed at improving transparency among clinical trial funders.
There are substantial limitations to depending only on institutional investigations of scientific misconduct.
Approximately 5% of patients in the United States contribute to half of total health care spending.
Study investigators asked physicians whether they perceived specific clinical examples as an ethical dilemma.
Both clinicians and patients alike can sometimes make irrational treatment choices based on reward, risks, time, and potential trade-offs associated with therapy.
Economic disparities and shortages of healthcare professionals worldwide have been implicated as key contributors to inadequate global healthcare access, particularly among individuals living in rural, low-income areas.
Scientists continue to be the targets of legal action from pharmaceutical, medical device, and nutraceutical companies when published studies frame these companies’ products in an unfavorable light.
New use of antiepileptic drugs, particularly phenytoin, carbamazepine, and lamotrigine, is associated with an increased risk for Stevens-Johnson syndrome and toxic epidermal necrolysis.
Intravenous omadacycline and once-per-day oral omadacycline have efficacy and tolerability profiles similar to those of IV and oral linezolid in overweight/obese patients with diabetes and acute bacterial skin and skin structure infection.